Depression and anxiety, the two most common mental health conditions, cost the global economy US$1 trillion each year and the World Health Organization has called for a transformation in global mental health care.
The PRISM Emerging Mental Health Index tracks small and micro-cap stocks that are contributing to advancing mental health care.
| PRISM Emerging Mental Health IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| 1.5% | $69.90 | -30.1% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| Reviva Pharmaceuticals Holdings, Inc. | RVPH | $1.86 | 4.494% | 2,358 | 1,977 | $87 | $5.31 | -65.0% |
| Seelos Therapeutics, Inc. | SEEL | $0.37 | -31.494% | 29 | 484 | $0 | $1.38 | -73.2% |
| Talkspace, Inc. | TALK | $3.22 | 6.623% | 1,198 | 2,015 | $544 | $2.38 | 35.3% |
| ABVC BioPharma, Inc. | ABVC | $0.56 | 7.541% | 217 | 256 | $7 | $1.20 | -53.4% |
| Bionomics Limited | BNOX | $0.25 | 4.587% | 906 | 853 | $892 | $1.35 | -81.3% |
| Sage Therapeutics, Inc. | SAGE | $5.73 | 4.562% | 766 | 950 | $351 | $22.48 | -74.5% |
| VistaGen Therapeutics, Inc. | VTGN | $2.60 | 1.961% | 615 | 242 | $72 | $5.15 | -49.5% |
| Alzamend Neuro, Inc. | ALZN | $1.24 | 4.202% | 100 | 209 | $7 | $0.92 | 34.8% |
| BioXcel Therapeutics, Inc. | BTAI | $0.37 | 5.953% | 1,746 | 608 | $18 | $2.93 | -87.3% |
| Cingulate Inc. | CING | $4.82 | -0.823% | 97 | 135 | $15 | $6.72 | -28.3% |
| BrainsWay Ltd. | BWAY | $9.37 | 0.214% | 28 | 91 | $176 | $7.22 | 29.8% |
| Anavex Life Sciences Corp. | AVXL | $12.56 | 15.547% | 6,276 | 1,364 | $1,065 | $6.05 | 107.8% |
| Vanda Pharmaceuticals Inc. | VNDA | $4.81 | -0.414% | 378 | 659 | $280 | $4.52 | 6.4% |
| Numinus Wellness Inc. | NUMIF | $0.02 | 2.083% | 3 | 229 | $8 | $0.08 | -69.8% |
| NRx Pharmaceuticals, Inc. | NRXP | $1.53 | -2.548% | 1,766 | 214 | $19 | $4.99 | -69.3% |
| ACADIA Pharmaceuticals Inc. | ACAD | $17.37 | 1.758% | 734 | 1,460 | $2,890 | $30.86 | -43.7% |
